APVO vs AMGN: Which Stock is Better?
Side-by-side comparison of Aptevo Therapeutics Inc and Amgen Inc in 2026
APVO
Aptevo Therapeutics Inc
$4.42
AMGN
Amgen Inc
$366.21
Key Metrics Comparison
| Metric | APVO | AMGN | Winner |
|---|---|---|---|
| Market Cap | $6.90M | $197.41B | AMGN |
| P/E Ratio | 0.00 | 25.70 | APVO |
| EPS (TTM) | $7758.20 | $14.25 | APVO |
| Revenue Growth | -1.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze APVO
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APVO or AMGN a better investment?
Comparing APVO and AMGN: Aptevo Therapeutics Inc has a market cap of $6.90M while Amgen Inc has $197.41B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APVO and AMGN?
APVO (Aptevo Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APVO or AMGN?
Based on P/E ratios, APVO trades at a lower multiple (0.0x vs 25.7x).
Which is growing faster: APVO or AMGN?
AMGN has higher revenue growth at 0.1% vs -1.0% for APVO.
Which company is more profitable: APVO or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for APVO.
Which is the larger company: APVO or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $197.41B compared to $6.90M for APVO.
Should I buy APVO or AMGN in 2026?
Both APVO and AMGN have investment merit. APVO trades at $4.42 while AMGN trades at $366.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APVO and AMGN stock?
Key differences: Market Cap ($6.90M vs $197.41B), P/E Ratio (0.0x vs 25.7x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).